Critically, expression of the MAPKAP1 deletion hindered the subcutaneous growth of H-Ras mutant bladder cancer, K-Ras mutant colon cancer and N-Ras mutant melanoma cancer cells, but not tumorigenesis of cancer tissue type-matched wild-type Ras cells. Here, KRAS is linked to cancer.